2023-2027 年全球基因治療市場
市場調查報告書
商品編碼
1229027

2023-2027 年全球基因治療市場

Global Gene Therapy Market 2023-2027

出版日期: | 出版商: TechNavio | 英文 161 Pages | 訂單完成後即時交付

價格

報告預測,2022年至2027年基因治療市場規模預計將增加46.139億美元,預測期內復合年增長率為19.91%。

本報告提供了基因治療市場、市場規模和預測、趨勢、增長驅動因素和挑戰的總體分析,以及涵蓋約 25 家供應商的供應商分析。

我們提供對當前市場趨勢和驅動因素以及整體市場環境的最新分析。 銀彈的興起、與基因治療相關的收益以及慢性病的流行推動了市場的發展。

  • 按治療領域
  • 腫瘤科
  • 中樞神經系統
  • 眼科
  • 罕見病
  • 其他

該研究指出,擴大對 CVD 和罕見疾病基因治療的研究是未來幾年推動基因治療市場增長的關鍵因素之一。 此外,新興經濟體快速增長的潛力和不斷增加的基因治療臨床管道預計將導致巨大的市場需求。

內容

第 1 章執行摘要

  • 市場概覽

第二章市場狀況

  • 市場生態系統

第三章市場規模

  • 市場定義
  • 市場細分分析
  • 2022 年市場規模
  • 市場展望:2022-2027 年預測

第 4 章市場規模結果

  • 2017-2021 年全球基因治療市場
  • 2017-2021 年治療領域細分分析
  • 2017-2021 年交付模式細分分析
  • 2017-2021 年區域細分分析
  • 2017-2021 年國家/地區細分分析

第五章五力分析

  • 五力總結
  • 買家的議價能力
  • 供應商的議價能力
  • 新進入者的威脅
  • 替代品的威脅
  • 競爭威脅
  • 市場

第 6 章治療領域的市場細分

  • 市場細分
  • 按治療領域進行比較
  • 腫瘤學 - 2022 年至 2027 年的市場規模和預測
  • CNS - 2022-2027 年市場規模和預測
  • 眼科 – 2022-2027 年市場規模和預測
  • 罕見病 - 2022-2027 年市場規模和預測
  • 其他 - 2022 年至 2027 年的市場規模和預測
  • 按治療領域劃分的市場機會

第 7 章按分銷模式進行市場細分

  • 市場細分
  • 按交付方式比較
  • In vivo - 2022-2027 年市場規模和預測
  • Ex vivo - 2022-2027 年市場規模和預測
  • 按交付模式劃分的市場機會

第八章客戶情況

  • 客戶情況總結

第九章區域情況

  • 區域細分
  • 按地區比較
  • 北美 - 2022-2027 年市場規模和預測
  • 歐洲 - 2022 年至 2027 年的市場規模和預測
  • 亞洲 – 2022-2027 年市場規模和預測
  • 世界其他地區 (ROW) – 市場規模和 2022-2027 年預測
  • 美國 - 2022-2027 年市場規模和預測
  • 英國 - 2022-2027 年市場規模和預測
  • 中國 - 2022-2027 年市場規模和預測
  • 加拿大 - 2022-2027 年市場規模和預測
  • 日本 - 2022-2027 年市場規模和預測
  • 各地區的市場機會

第 10 章驅動因素、挑戰和趨勢

  • 市場驅動力
  • 市場挑戰
  • 挑戰的驅動因素和影響
  • 市場趨勢

第 11 章供應商概況

  • 概覽
  • 供應商情況
  • 混亂情況
  • 行業風險

第 12 章供應商分析

  • 目標供應商
  • 供應商市場定位
  • Abeona Therapeutics Inc.
  • Amgen Inc.
  • Astellas Pharma Inc.
  • Biogen Inc.
  • bluebird bio Inc.
  • ElevateBio
  • F. Hoffmann La Roche Ltd.
  • Generation Bio Co.
  • Gilead Sciences Inc.
  • Novartis AG
  • Orchard Therapeutics Plc
  • Poseida Therapeutics Inc.
  • Sibiono GeneTech Co. Ltd.
  • uniQure NV
  • Voyager Therapeutics Inc.

第13章 附錄

Product Code: IRTNTR73059

Technavio has been monitoring the gene therapy market and is forecast to grow by $4613.9 mn during 2022-2027, accelerating at a CAGR of 19.91% during the forecast period. Our report on the gene therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in special drug designations, benefits associated with gene therapy, and increasing prevalence of chronic diseases.

Technavio's gene therapy market is segmented as below:

  • By Therapy Area
  • Oncology
  • CNS
  • Ophthalmology
  • Rare diseases
  • Others

By Delivery Mode

  • In vivo
  • Ex vivo

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the growing research in gene therapy for CVDs and orphan diseases as one of the prime reasons driving the gene therapy market growth during the next few years. Also, rapid growth potential in developing economies and rise in clinical pipeline for gene therapy will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the gene therapy market covers the following areas:

  • Gene therapy market sizing
  • Gene therapy market forecast
  • Gene therapy market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gene therapy market vendors that include Abeona Therapeutics Inc., Adaptimmune Therapeutics plc, Adverum Biotechnologies Inc., Amgen Inc., Astellas Pharma Inc., Biogen Inc., bluebird bio Inc., Editas Medicine Inc., ElevateBio, F. Hoffmann La Roche Ltd., Generation Bio Co., Gilead Sciences Inc., Novartis AG, Orchard Therapeutics Plc, Poseida Therapeutics Inc., Sangamo Therapeutics Inc., Sibiono GeneTech Co. Ltd., Syncona Ltd., uniQure NV, and Voyager Therapeutics Inc. Also, the gene therapy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market by Geography
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapy Area
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Delivery Mode
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global gene therapy market 2017 - 2021
  • Exhibit 18: Historic Market Size - Data Table on Global gene therapy market 2017 - 2021 ($ million)
  • 4.2 Therapy area Segment Analysis 2017 - 2021
  • Exhibit 19: Historic Market Size - Therapy area Segment 2017 - 2021 ($ million)
  • 4.3 Delivery mode Segment Analysis 2017 - 2021
  • Exhibit 20: Historic Market Size - Delivery mode Segment 2017 - 2021 ($ million)
  • 4.4 Geography Segment Analysis 2017 - 2021
  • Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • 4.5 Country Segment Analysis 2017 - 2021
  • Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Therapy Area

  • 6.1 Market segments
  • Exhibit 30: Chart on Therapy Area - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on Therapy Area - Market share 2022-2027 (%)
  • 6.2 Comparison by Therapy Area
  • Exhibit 32: Chart on Comparison by Therapy Area
  • Exhibit 33: Data Table on Comparison by Therapy Area
  • 6.3 Oncology - Market size and forecast 2022-2027
  • Exhibit 34: Chart on Oncology - Market size and forecast 2022-2027 ($ million)
  • Exhibit 35: Data Table on Oncology - Market size and forecast 2022-2027 ($ million)
  • Exhibit 36: Chart on Oncology - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
  • 6.4 CNS - Market size and forecast 2022-2027
  • Exhibit 38: Chart on CNS - Market size and forecast 2022-2027 ($ million)
  • Exhibit 39: Data Table on CNS - Market size and forecast 2022-2027 ($ million)
  • Exhibit 40: Chart on CNS - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on CNS - Year-over-year growth 2022-2027 (%)
  • 6.5 Ophthalmology - Market size and forecast 2022-2027
  • Exhibit 42: Chart on Ophthalmology - Market size and forecast 2022-2027 ($ million)
  • Exhibit 43: Data Table on Ophthalmology - Market size and forecast 2022-2027 ($ million)
  • Exhibit 44: Chart on Ophthalmology - Year-over-year growth 2022-2027 (%)
  • Exhibit 45: Data Table on Ophthalmology - Year-over-year growth 2022-2027 (%)
  • 6.6 Rare diseases - Market size and forecast 2022-2027
  • Exhibit 46: Chart on Rare diseases - Market size and forecast 2022-2027 ($ million)
  • Exhibit 47: Data Table on Rare diseases - Market size and forecast 2022-2027 ($ million)
  • Exhibit 48: Chart on Rare diseases - Year-over-year growth 2022-2027 (%)
  • Exhibit 49: Data Table on Rare diseases - Year-over-year growth 2022-2027 (%)
  • 6.7 Others - Market size and forecast 2022-2027
  • Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
  • Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
  • Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
  • Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
  • 6.8 Market opportunity by Therapy Area
  • Exhibit 54: Market opportunity by Therapy Area ($ million)

7 Market Segmentation by Delivery Mode

  • 7.1 Market segments
  • Exhibit 55: Chart on Delivery Mode - Market share 2022-2027 (%)
  • Exhibit 56: Data Table on Delivery Mode - Market share 2022-2027 (%)
  • 7.2 Comparison by Delivery Mode
  • Exhibit 57: Chart on Comparison by Delivery Mode
  • Exhibit 58: Data Table on Comparison by Delivery Mode
  • 7.3 In vivo - Market size and forecast 2022-2027
  • Exhibit 59: Chart on In vivo - Market size and forecast 2022-2027 ($ million)
  • Exhibit 60: Data Table on In vivo - Market size and forecast 2022-2027 ($ million)
  • Exhibit 61: Chart on In vivo - Year-over-year growth 2022-2027 (%)
  • Exhibit 62: Data Table on In vivo - Year-over-year growth 2022-2027 (%)
  • 7.4 Ex vivo - Market size and forecast 2022-2027
  • Exhibit 63: Chart on Ex vivo - Market size and forecast 2022-2027 ($ million)
  • Exhibit 64: Data Table on Ex vivo - Market size and forecast 2022-2027 ($ million)
  • Exhibit 65: Chart on Ex vivo - Year-over-year growth 2022-2027 (%)
  • Exhibit 66: Data Table on Ex vivo - Year-over-year growth 2022-2027 (%)
  • 7.5 Market opportunity by Delivery Mode
  • Exhibit 67: Market opportunity by Delivery Mode ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 69: Chart on Market share by geography 2022-2027 (%)
  • Exhibit 70: Data Table on Market share by geography 2022-2027 (%)
  • 9.2 Geographic comparison
  • Exhibit 71: Chart on Geographic comparison
  • Exhibit 72: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027
  • Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Europe - Market size and forecast 2022-2027
  • Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.5 Asia - Market size and forecast 2022-2027
  • Exhibit 81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 83: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 9.7 US - Market size and forecast 2022-2027
  • Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.8 UK - Market size and forecast 2022-2027
  • Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • 9.9 China - Market size and forecast 2022-2027
  • Exhibit 97: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 98: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 99: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibit 100: Data Table on China - Year-over-year growth 2022-2027 (%)
  • 9.10 Canada - Market size and forecast 2022-2027
  • Exhibit 101: Chart on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibit 102: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibit 103: Chart on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibit 104: Data Table on Canada - Year-over-year growth 2022-2027 (%)
  • 9.11 Japan - Market size and forecast 2022-2027
  • Exhibit 105: Chart on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibit 106: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibit 107: Chart on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibit 108: Data Table on Japan - Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity by geography
  • Exhibit 109: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 110: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 112: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 113: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 114: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 115: Matrix on vendor position and classification
  • 12.3 Abeona Therapeutics Inc.
  • Exhibit 116: Abeona Therapeutics Inc. - Overview
  • Exhibit 117: Abeona Therapeutics Inc. - Product / Service
  • Exhibit 118: Abeona Therapeutics Inc. - Key offerings
  • 12.4 Amgen Inc.
  • Exhibit 119: Amgen Inc. - Overview
  • Exhibit 120: Amgen Inc. - Product / Service
  • Exhibit 121: Amgen Inc. - Key offerings
  • 12.5 Astellas Pharma Inc.
  • Exhibit 122: Astellas Pharma Inc. - Overview
  • Exhibit 123: Astellas Pharma Inc. - Product / Service
  • Exhibit 124: Astellas Pharma Inc. - Key offerings
  • 12.6 Biogen Inc.
  • Exhibit 125: Biogen Inc. - Overview
  • Exhibit 126: Biogen Inc. - Product / Service
  • Exhibit 127: Biogen Inc. - Key offerings
  • 12.7 bluebird bio Inc.
  • Exhibit 128: bluebird bio Inc. - Overview
  • Exhibit 129: bluebird bio Inc. - Product / Service
  • Exhibit 130: bluebird bio Inc. - Key offerings
  • 12.8 ElevateBio
  • Exhibit 131: ElevateBio - Overview
  • Exhibit 132: ElevateBio - Product / Service
  • Exhibit 133: ElevateBio - Key offerings
  • 12.9 F. Hoffmann La Roche Ltd.
  • Exhibit 134: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 135: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 136: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 137: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 138: F. Hoffmann La Roche Ltd. - Segment focus
  • 12.10 Generation Bio Co.
  • Exhibit 139: Generation Bio Co. - Overview
  • Exhibit 140: Generation Bio Co. - Product / Service
  • Exhibit 141: Generation Bio Co. - Key offerings
  • 12.11 Gilead Sciences Inc.
  • Exhibit 142: Gilead Sciences Inc. - Overview
  • Exhibit 143: Gilead Sciences Inc. - Product / Service
  • Exhibit 144: Gilead Sciences Inc. - Key news
  • Exhibit 145: Gilead Sciences Inc. - Key offerings
  • 12.12 Novartis AG
  • Exhibit 146: Novartis AG - Overview
  • Exhibit 147: Novartis AG - Business segments
  • Exhibit 148: Novartis AG - Key offerings
  • Exhibit 149: Novartis AG - Segment focus
  • 12.13 Orchard Therapeutics Plc
  • Exhibit 150: Orchard Therapeutics Plc - Overview
  • Exhibit 151: Orchard Therapeutics Plc - Product / Service
  • Exhibit 152: Orchard Therapeutics Plc - Key offerings
  • 12.14 Poseida Therapeutics Inc.
  • Exhibit 153: Poseida Therapeutics Inc. - Overview
  • Exhibit 154: Poseida Therapeutics Inc. - Product / Service
  • Exhibit 155: Poseida Therapeutics Inc. - Key offerings
  • 12.15 Sibiono GeneTech Co. Ltd.
  • Exhibit 156: Sibiono GeneTech Co. Ltd. - Overview
  • Exhibit 157: Sibiono GeneTech Co. Ltd. - Product / Service
  • Exhibit 158: Sibiono GeneTech Co. Ltd. - Key offerings
  • 12.16 uniQure NV
  • Exhibit 159: uniQure NV - Overview
  • Exhibit 160: uniQure NV - Product / Service
  • Exhibit 161: uniQure NV - Key offerings
  • 12.17 Voyager Therapeutics Inc.
  • Exhibit 162: Voyager Therapeutics Inc. - Overview
  • Exhibit 163: Voyager Therapeutics Inc. - Product / Service
  • Exhibit 164: Voyager Therapeutics Inc. - Key offerings

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 165: Inclusions checklist
  • Exhibit 166: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 167: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 168: Research methodology
  • Exhibit 169: Validation techniques employed for market sizing
  • Exhibit 170: Information sources
  • 13.5 List of abbreviations
  • Exhibit 171: List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market by Geography
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy Area
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Delivery Mode
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits18: Historic Market Size - Data Table on Global gene therapy market 2017 - 2021 ($ million)
  • Exhibits19: Historic Market Size - Therapy area Segment 2017 - 2021 ($ million)
  • Exhibits20: Historic Market Size - Delivery mode Segment 2017 - 2021 ($ million)
  • Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
  • Exhibits23: Five forces analysis - Comparison between 2022 and 2027
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • Exhibits29: Chart on Market condition - Five forces 2022 and 2027
  • Exhibits30: Chart on Therapy Area - Market share 2022-2027 (%)
  • Exhibits31: Data Table on Therapy Area - Market share 2022-2027 (%)
  • Exhibits32: Chart on Comparison by Therapy Area
  • Exhibits33: Data Table on Comparison by Therapy Area
  • Exhibits34: Chart on Oncology - Market size and forecast 2022-2027 ($ million)
  • Exhibits35: Data Table on Oncology - Market size and forecast 2022-2027 ($ million)
  • Exhibits36: Chart on Oncology - Year-over-year growth 2022-2027 (%)
  • Exhibits37: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
  • Exhibits38: Chart on CNS - Market size and forecast 2022-2027 ($ million)
  • Exhibits39: Data Table on CNS - Market size and forecast 2022-2027 ($ million)
  • Exhibits40: Chart on CNS - Year-over-year growth 2022-2027 (%)
  • Exhibits41: Data Table on CNS - Year-over-year growth 2022-2027 (%)
  • Exhibits42: Chart on Ophthalmology - Market size and forecast 2022-2027 ($ million)
  • Exhibits43: Data Table on Ophthalmology - Market size and forecast 2022-2027 ($ million)
  • Exhibits44: Chart on Ophthalmology - Year-over-year growth 2022-2027 (%)
  • Exhibits45: Data Table on Ophthalmology - Year-over-year growth 2022-2027 (%)
  • Exhibits46: Chart on Rare diseases - Market size and forecast 2022-2027 ($ million)
  • Exhibits47: Data Table on Rare diseases - Market size and forecast 2022-2027 ($ million)
  • Exhibits48: Chart on Rare diseases - Year-over-year growth 2022-2027 (%)
  • Exhibits49: Data Table on Rare diseases - Year-over-year growth 2022-2027 (%)
  • Exhibits50: Chart on Others - Market size and forecast 2022-2027 ($ million)
  • Exhibits51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
  • Exhibits52: Chart on Others - Year-over-year growth 2022-2027 (%)
  • Exhibits53: Data Table on Others - Year-over-year growth 2022-2027 (%)
  • Exhibits54: Market opportunity by Therapy Area ($ million)
  • Exhibits55: Chart on Delivery Mode - Market share 2022-2027 (%)
  • Exhibits56: Data Table on Delivery Mode - Market share 2022-2027 (%)
  • Exhibits57: Chart on Comparison by Delivery Mode
  • Exhibits58: Data Table on Comparison by Delivery Mode
  • Exhibits59: Chart on In vivo - Market size and forecast 2022-2027 ($ million)
  • Exhibits60: Data Table on In vivo - Market size and forecast 2022-2027 ($ million)
  • Exhibits61: Chart on In vivo - Year-over-year growth 2022-2027 (%)
  • Exhibits62: Data Table on In vivo - Year-over-year growth 2022-2027 (%)
  • Exhibits63: Chart on Ex vivo - Market size and forecast 2022-2027 ($ million)
  • Exhibits64: Data Table on Ex vivo - Market size and forecast 2022-2027 ($ million)
  • Exhibits65: Chart on Ex vivo - Year-over-year growth 2022-2027 (%)
  • Exhibits66: Data Table on Ex vivo - Year-over-year growth 2022-2027 (%)
  • Exhibits67: Market opportunity by Delivery Mode ($ million)
  • Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits69: Chart on Market share by geography 2022-2027 (%)
  • Exhibits70: Data Table on Market share by geography 2022-2027 (%)
  • Exhibits71: Chart on Geographic comparison
  • Exhibits72: Data Table on Geographic comparison
  • Exhibits73: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits75: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits76: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits79: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits83: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits89: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits90: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits91: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibits92: Data Table on US - Year-over-year growth 2022-2027 (%)
  • Exhibits93: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits95: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits96: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits97: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits98: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits99: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibits100: Data Table on China - Year-over-year growth 2022-2027 (%)
  • Exhibits101: Chart on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibits102: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibits103: Chart on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibits104: Data Table on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibits105: Chart on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibits106: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibits107: Chart on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibits108: Data Table on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibits109: Market opportunity by geography ($ million)
  • Exhibits110: Impact of drivers and challenges in 2022 and 2027
  • Exhibits111: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits112: Overview on factors of disruption
  • Exhibits113: Impact of key risks on business
  • Exhibits114: Vendors covered
  • Exhibits115: Matrix on vendor position and classification
  • Exhibits116: Abeona Therapeutics Inc. - Overview
  • Exhibits117: Abeona Therapeutics Inc. - Product / Service
  • Exhibits118: Abeona Therapeutics Inc. - Key offerings
  • Exhibits119: Amgen Inc. - Overview
  • Exhibits120: Amgen Inc. - Product / Service
  • Exhibits121: Amgen Inc. - Key offerings
  • Exhibits122: Astellas Pharma Inc. - Overview
  • Exhibits123: Astellas Pharma Inc. - Product / Service
  • Exhibits124: Astellas Pharma Inc. - Key offerings
  • Exhibits125: Biogen Inc. - Overview
  • Exhibits126: Biogen Inc. - Product / Service
  • Exhibits127: Biogen Inc. - Key offerings
  • Exhibits128: bluebird bio Inc. - Overview
  • Exhibits129: bluebird bio Inc. - Product / Service
  • Exhibits130: bluebird bio Inc. - Key offerings
  • Exhibits131: ElevateBio - Overview
  • Exhibits132: ElevateBio - Product / Service
  • Exhibits133: ElevateBio - Key offerings
  • Exhibits134: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits135: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits136: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits137: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits138: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits139: Generation Bio Co. - Overview
  • Exhibits140: Generation Bio Co. - Product / Service
  • Exhibits141: Generation Bio Co. - Key offerings
  • Exhibits142: Gilead Sciences Inc. - Overview
  • Exhibits143: Gilead Sciences Inc. - Product / Service
  • Exhibits144: Gilead Sciences Inc. - Key news
  • Exhibits145: Gilead Sciences Inc. - Key offerings
  • Exhibits146: Novartis AG - Overview
  • Exhibits147: Novartis AG - Business segments
  • Exhibits148: Novartis AG - Key offerings
  • Exhibits149: Novartis AG - Segment focus
  • Exhibits150: Orchard Therapeutics Plc - Overview
  • Exhibits151: Orchard Therapeutics Plc - Product / Service
  • Exhibits152: Orchard Therapeutics Plc - Key offerings
  • Exhibits153: Poseida Therapeutics Inc. - Overview
  • Exhibits154: Poseida Therapeutics Inc. - Product / Service
  • Exhibits155: Poseida Therapeutics Inc. - Key offerings
  • Exhibits156: Sibiono GeneTech Co. Ltd. - Overview
  • Exhibits157: Sibiono GeneTech Co. Ltd. - Product / Service
  • Exhibits158: Sibiono GeneTech Co. Ltd. - Key offerings
  • Exhibits159: uniQure NV - Overview
  • Exhibits160: uniQure NV - Product / Service
  • Exhibits161: uniQure NV - Key offerings
  • Exhibits162: Voyager Therapeutics Inc. - Overview
  • Exhibits163: Voyager Therapeutics Inc. - Product / Service
  • Exhibits164: Voyager Therapeutics Inc. - Key offerings
  • Exhibits165: Inclusions checklist
  • Exhibits166: Exclusions checklist
  • Exhibits167: Currency conversion rates for US$
  • Exhibits168: Research methodology
  • Exhibits169: Validation techniques employed for market sizing
  • Exhibits170: Information sources
  • Exhibits171: List of abbreviations